14.50
1.59 (12.32%)
1.59 (12.32%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Altimmune Inc | ALT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 1.59 | 12.32% | 14.50 | 19:48:46 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 12.99 | 12.82 | 14.87 | 14.35 | 12.91 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 14.38 | 14.50 | 0.12 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12,393 | 2,341,566 | $ 14.01 | $ 32,796,947 | 1,606,120 | 1.60 - 35.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:13 | 50 | $ 14.50 | USD |
Altimmune Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 538.57M | 37.14M | 32.26M | $ 5.80M | $ - | -1.52 | -6.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Altimmune News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ALT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 13.75 | 14.87 | 12.6101 | 13.19 | 1,092,992 | 0.75 | 5.45% |
| 1 Month | 12.06 | 14.87 | 10.46 | 12.68 | 1,358,430 | 2.44 | 20.23% |
| 3 Months | 11.24 | 15.37 | 7.80 | 11.71 | 1,762,609 | 3.26 | 29.0% |
| 6 Months | 31.5751 | 35.00 | 7.80 | 15.18 | 1,704,281 | -17.08 | -54.08% |
| 1 Year | 1.97 | 35.10 | 1.60 | 12.97 | 2,467,980 | 12.53 | 636.04% |
| 3 Years | 1.82 | 36.25 | 0.245 | 9.54 | 1,270,602 | 12.68 | 696.7% |
| 5 Years | 7.31 | 36.25 | 0.245 | 9.37 | 1,053,617 | 7.19 | 98.36% |
Altimmune Description
| Altimmune Inc is a United States-based clinical-stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of liver diseases. The firm's product candidates include NasoVAX, HepTcell, SparVax-L, and NasoShield. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts. |
